poisar

Stocks · News reference

Intensity Therapeutics Q2 EPS $(1.11), Inline

BenzingaAug 11, 2026, 11:52 AMBenzinga Newsdesk

Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(1.11) per share which met the analyst consensus estimate. This is a 66.96 percent increase over losses of $(3.36) per share from the same period last

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 11, 2026, 11:52 AM
Checked
Aug 11, 2026, 11:52 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading